Clinical Trial Update: First-in-Human Study of the Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Profile of VX-984 in Combination With Chemotherapy [Phase 1]

View source ↗

Summary

First-in-human Phase 1 trial assessing safety, tolerability, and PK/PD of VX-984 in combination with chemotherapy in patients with advanced solid tumors; study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• VX-984 (VX-984)

Snippet

Sponsor: EMD Serono Research & Development Institute, Inc. | Conditions: Advanced Solid Tumor | Phase 1 | Status: COMPLETED | Results posted: 2019-09-09